20 September 2024
Kropz plc
("Kropz" or the "Company")
Results of General Meeting
Kropz plc (AIM: KRPZ), an emerging African phosphate producer, is pleased to announce that all the resolutions put to its General Meeting ("GM") held earlier today, 20 September 2024, were duly passed on a poll. A breakdown of proxy votes lodged prior to the GM will be available shortly on the Company's website.
As announced on 3 September 2024, the purpose of the GM was to provide the Company's directors authority to issue and allot shares and the disapplication in respect of pre-emption rights in respect of new ordinary shares which are to be issued pursuant to the Fundraising and the issue of Convertible Loan Notes as part of the Restructuring.
The Restructuring, Fundraising and the issue of the Convertible Loan Notes are also conditional on receiving approval from the South African Reserve Bank ("Exchange Control Approval"). The Company has not yet received Exchange Control Approval. The Company will make a further announcement upon receipt of the Exchange Control Approval in due course and will confirm the issue and Admission of the Fundraising shares at that time.
For further information visit www.kropz.com or contact:
|
Kropz Plc |
Via Tavistock |
|
Louis Loubser (CEO) |
+44 (0) 207 920 3150 |
|
|
|
|
Grant Thornton UK LLP |
Nominated Adviser |
|
Samantha Harrison Harrison Clarke Ciara Donnelly |
+44 (0) 20 7383 5100 |
|
|
|
|
Hannam & Partners |
Broker |
|
Andrew Chubb Ernest Bell |
+44 (0) 20 7907 8500 |
|
|
|
|
Tavistock |
Financial PR & IR (UK) |
|
Nick Elwes Jos Simson
|
+44 (0) 207 920 3150 kropz@tavistock.co.uk |
|
|
|
|
R&A Strategic Communications |
PR (South Africa) |
|
Charmane Russell Marion Brower |
+27 (0) 11 880 3924 charmane@rasc.co.za marion@rasc.co.za
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
